<DOC>
<DOCNO>
EP-0012699
</DOCNO>
<TEXT>
<DATE>
19800625
</DATE>
<IPC-CLASSIFICATIONS>
<main>G01N-33/543</main> G01N-33/576 
</IPC-CLASSIFICATIONS>
<TITLE>
process for detecting hepatitis b core antibody (hbcab) in biological fluid.
</TITLE>
<APPLICANT>
merck & co inc us  <sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
callahan lynn t<sep>mcaleer william j<sep>miller william j<sep>callahan, lynn t.<sep>mcaleer, william j.<sep>miller, william j.<sep>callahan, lynn t.pennbrooke, apt. 7k 131 church roadnorth wales, pennsylvania 19454us<sep>mcaleer, william j.717 marietta driveambler, pennsylvania 19002us<sep>miller, william j.1408 sandy's lanenorth wales, pennsylvania 19454us<sep>callahan, lynn t.<sep>mcaleer, william j. <sep>miller, william j.<sep>callahan, lynn t. pennbrooke, apt. 7k 131 church road north wales, pennsylvania 19454 us <sep>mcaleer, william j.717 marietta driveambler, pennsylvania 19002us<sep>miller, william j.1408 sandy's lanenorth wales, pennsylvania 19454us<sep>
</INVENTOR>
<ABSTRACT>
hbcab is detected in biological fluid by contacting  hbcag derived from dane particles and adhered to a surfa­ ce with the biological fluid and an antibody-enzyme conju­ gate.  the hbcag ist adhered to the surface in the presen­ ce of a nonionic surfactant.  
</ABSTRACT>
</TEXT>
</DOC>
